Prestige Consumer Healthcare Inc. amended its Term Loan Credit Agreement on July 1, 2026, to permit additional borrowing of up to $95.0 million. The company utilized $95,000,000 of this capacity on the same date to finance the acquisition of several Australian entities, including LaCorium Health Australia Pty Limited and Laderma Holdings Pty Limited. Additionally, the company announced the commencement of a $400,000,000 private offering of senior unsecured notes due 2034 and subsequently confirmed the pricing of these notes following the LaCorium acquisition. Prestige Consumer Healthcare Inc. is a consumer healthcare company that develops and markets branded consumer products.
